gamma-aminobutyric acid has been researched along with Myasthenia Gravis in 4 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In order to avoid drug interactions as well as adverse effects of carbamazepine in myasthenia gravis, gabapentin was chosen for the treatment of neuropathic pain." | 7.72 | Treatment of post-herpetic pain in myasthenia gravis: exacerbation of weakness due to gabapentin. ( Beuche, W; Scheschonka, A, 2003) |
| " In order to avoid drug interactions as well as adverse effects of carbamazepine in myasthenia gravis, gabapentin was chosen for the treatment of neuropathic pain." | 3.72 | Treatment of post-herpetic pain in myasthenia gravis: exacerbation of weakness due to gabapentin. ( Beuche, W; Scheschonka, A, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheen, VL | 1 |
| Ohaegbulam, C | 1 |
| Rencus, T | 1 |
| Tandon, D | 1 |
| Benjaminsen, E | 1 |
| Skjeflo, GW | 1 |
| Dybwik, K | 1 |
| Salvesen, R | 1 |
| Scheschonka, A | 1 |
| Beuche, W | 1 |
| Boneva, N | 1 |
| Brenner, T | 1 |
| Argov, Z | 1 |
4 other studies available for gamma-aminobutyric acid and Myasthenia Gravis
| Article | Year |
|---|---|
Gabapentin-induced exacerbation of myasthenia gravis.
Topics: Aged; Amines; Cholinesterase Inhibitors; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagoni | 2010 |
A man in his seventies with prolonged myasthenic crisis.
Topics: Aged; Amines; Anti-Bacterial Agents; Antibodies, Monoclonal, Murine-Derived; Cyclohexanecarboxylic A | 2012 |
Treatment of post-herpetic pain in myasthenia gravis: exacerbation of weakness due to gabapentin.
Topics: Acetates; Amines; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Herpes Z | 2003 |
Gabapentin may be hazardous in myasthenia gravis.
Topics: Acetates; Action Potentials; Aged; Amines; Animals; Anticonvulsants; Autoantibodies; Cholinesterase | 2000 |